Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.6 USD | -0.58% | +2.78% | +11.57% |
May. 14 | Transcript : Kiniksa Pharmaceuticals, Ltd. Presents at Bank of America Health Care Conference 2024, May-14-2024 10:40 AM | |
Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.57% | 1.4B | |
+15.68% | 121B | |
+13.26% | 107B | |
-3.72% | 24.82B | |
+1.40% | 22.48B | |
-9.81% | 18.32B | |
-42.28% | 16.33B | |
-16.46% | 15.31B | |
+4.50% | 14.08B | |
+26.79% | 11.74B |
- Stock Market
- Equities
- KNSA Stock
- News Kiniksa Pharmaceuticals, Ltd.
- Wedbush Lifts Price Target on Kiniksa Pharmaceuticals to $26 From $25, Keeps Outperform Rating